Sponsored Link:

Page Analysis

Sponsored Link:


708 ratings.1180 user reviews.

Web page information

  1. Keywords hit in search results
    ü about agreement america announced antibiotic appointment appoints approach ardea assistance asthma astrazeneca based billion biopharmaceutical biosciences brasil brazil breaking brito business cancer closed companies company completed contributor cotia development difference discover dividend driven drugs economic effective european focused friday glaxosmithkline global ground health human ideas information inhaled inhibitor innovation innovative integrated investment lackluster launched leading learn license licensing major marketing marta medicines north novartis patient paulo pence performance pfizer pharmaceuticals pioneering presence president price programs prosperity purchase raposo recently research resources rigel rodovia science share shares states stock tavare thursday today treat trial turning united websites weltweit world
  2. Search Engine Recommended Keywords
    AstraZeneca Patient Assistance Program, AstraZeneca Benefits, AstraZeneca Careers, AstraZeneca Seroquel, AstraZeneca Products, AstraZeneca Nexium, AstraZeneca Samples, AstraZeneca Drugs,
AstraZeneca Brasil
One of the world's leading biopharmaceutical companies, our business is focused on turning good ideas into innovative, effective medicines that make a real difference ...
AstraZeneca - a global research-based biopharmaceutical company
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. Discover the ground-breaking work that we do at AstraZeneca.com
AstraZeneca - Brazil
Rodovia Raposo Tavare KM 26 Cotia-Sao Paulo 55 11 3737 1200 55 11 4612 2574 http://www.astrazeneca.com.br/
AstraZeneca - Home
AstraZeneca is a major contributor to UK science and innovation investment, economic prosperity and to patient health. Read more about our UK presence
AstraZeneca appoints Marta Brito Pérez HR VP, North America and ...
AstraZeneca has announced the appointment of Marta Brito Pérez as Human Resources Vice President, North America and Global Marketing.
AstraZeneca - United States Home Page
Learn about AstraZeneca, a global, innovation-driven biopharmaceutical company, and get information on our medicines, patient assistance programs, and more.
AstraZeneca - Home
AstraZeneca Australia is engaged in the research, development, manufacture and supply of medicines that aim to make a real difference to the lives of Australians.
AstraZeneca Is Undervalued - Seeking Alpha
AstraZeneca (AZN) has had a lackluster stock price performance in recent years. Despite the lackluster stock price performance, AstraZeneca sports a high dividend ...
AstraZeneca Websites weltweit - AstraZeneca Deutschland
Eine Übersicht über alle AstraZeneca Websites weltweit ... Diese Seite bietet Links zu einer Anzahl AstraZeneca Websites, so auch Sites über unsere Produkte, die ...

News Results

AstraZeneca Will Soar On 2 New Drugs In 2013
Cancer Research UK's Drug Development Office has begun a clinical trial to test AstraZeneca's (AZN) AZD4547 drug. This drug may, if combined with chemotherapy, treat stomach or esophageal cancer. This is the first trial launched by the ECMC Combinations Alliance.
AstraZeneca Buys Ardea Biosciences
AstraZeneca plc (AZN) recently announced that it has completed the acquisition of Ardea Biosciences, Inc. for approximately $1.26 billion or $32 per share. Both AstraZeneca and Ardea’s boards unanimously supported the merger. Ardea’s ...
Yahoo Finance
UPDATE 1-Novartis, Astra win EU drug okays; Pfizer loses out
LONDON, June 22 (Reuters) - Novartis and AstraZeneca won recommendations for important new drugs from European regulators on Friday, while rival Pfizer lost out. The European Medicines Agency said its Committee for Medicinal Products for Human ...
AstraZeneca, RIGL in Licensing Deal
AstraZeneca (AZN) and Rigel Pharmaceuticals, Inc. (RIGL) recently announced that they have entered into a licensing agreement for Rigel’s asthma candidate, R256. Per the terms of the agreement, AstraZeneca will make an upfront payment of $1 ...
Yahoo Finance
AstraZeneca Completes Purchase of Ardea Biosciences (AZN)
Jun 20, 2012 (SmarTrend(R) News Watch via COMTEX) -- 6-20-2012- AstraZeneca PLC (NYSE:AZN) announced that it has completed its purchase of Ardea Biosciences Inc. The deal for AstraZeneca to acquire Ardea Biosciences for $1.26 billion was ...
AstraZeneca Buys 300,000 Shares to Cancel/2751P
AstraZeneca PLC announced Thursday that it purchased for cancellation 300,000 of its own ordinary shares at a price of 2751 pence per share. -Shares at 0725 GMT up 13 pence, or 0.5%, at 2,780 pence, valuing the company at GBP35.1 billion.
AstraZeneca, Rigel enter global license agreement for R256 inhaled JAK inhibitor to treat chronic asthma
AstraZeneca and Rigel Pharmaceuticals Inc. today announced an exclusive worldwide license agreement for the global development and commercialization of R256, Rigel's inhaled JAK inhibitor shown to inhibit IL-13 and IL-4 signalling, which is ...
GlaxoSmithKline and AstraZeneca launch pioneering approach to antibiotic research
It was announced today that GlaxoSmithKline and AstraZeneca have launched a pioneering approach to antibiotic research in Europe to attempt to tackle the rising threat from antibiotic resistance and address some of the key barriers to the development of ...
Transworld News
AstraZeneca: Get In Before The Bounce Back
AstraZeneca (AZN) continued its long decline last month with another round of bad news. Since it paid out a $1.95 dividend to shareholders last quarter, its stock price has dropped over $6. Going forward, I expect its price to continue to slide, as it will ...
AstraZeneca (AZN) Showing Bullish Technicals With Support At $42.54
Thursday, June 14, 2012... AstraZeneca (NYSE:AZN) closed Wednesday's downbeat trading session at $41.76. In the past year, the stock has hit a 52-week low of $39.72 and 52-week..... Friday, June 08, 2012... AstraZeneca Plc (NYSE: AZN) closed Thursday's ...
Market Intelligence Center
No Coupons found for this website.

500 characters left

Your Review: (5 out of 5)
refresh captcha

Server Information
IP Address:
Powered By:ASP.NET
Site Disclaimer:

All trademarks are the property of their respective owners. The facts, figures, reviews, records, stats, and other data presented on this page is for suggestion and information purposes only. PageGlimpse.com is not responsible for any incorrect or incomplete information. PageGlimpse.com does not take responsibility for any user-reviews of websites inside its resource and reserves the right to keep or remove those. It is highly recommended that you review all the data for accuracy.